Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 9/20 | 0.47 |
| ▸ | RAB9A | P51151 | 7/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.47 |
| ▸ | TERT | O14746 | 1/20 | 0.43 |
| ▸ | NQO2 | P16083 | 1/20 | 0.41 |
| ▸ | APAF1 | O14727 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.39 |
| ▸ | MAPT | P10636 | 7/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.39 |
| ▸ | HPGD | P15428 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 4/20 | 0.39 |
| ▸ | USP2 | O75604 | 3/20 | 0.39 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.39 |
| ▸ | APBA1 | Q02410 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL15265 | 1.00 | NPC1 (0.47) | NPC1RAB9AL3MBTL1NLRP3TERT | |
| Hydrochloric Acid SCHEMBL29353138 | 1.00 | NPC1 (0.47) | NPC1RAB9AL3MBTL1NLRP3TERT | |
| SCHEMBL31680480 | 1.00 | NPC1 (0.47) | NPC1RAB9AL3MBTL1NLRP3TERT | |
| SCHEMBL12336666 | 0.97 | NPC1 (0.45) | NPC1RAB9AL3MBTL1NLRP3TERT | |
| Butane SCHEMBL931598 | 0.94 | NPC1 (0.49) | NPC1RAB9AL3MBTL1NLRP3TERT | |
| SCHEMBL9279411 | 0.91 | NPC1 (0.41) | NPC1RAB9AL3MBTL1NLRP3TERT | |
| Hydrochloric Acid SCHEMBL20969348 | 0.91 | NPC1 (0.60) | NPC1RAB9AL3MBTL1NLRP3TERT | |
| SCHEMBL20969285 | 0.91 | NPC1 (0.60) | NPC1RAB9AL3MBTL1NLRP3TERT | |
| Hydrochloric Acid SCHEMBL11153458 | 0.89 | NPC1 (0.40) | NPC1RAB9AL3MBTL1NLRP3TERT | |
| SCHEMBL14065809 | 0.89 | NPC1 (0.45) | NPC1RAB9AL3MBTL1NLRP3TERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4137402-A | Quaternary ammonium salts of dantrolene and clodanolene | MORTON-NORWICH PRODUCTS, INC. (US) | 1979-01-30 | — | — | US | claimed |
| EP-4291587-A1 | PHOTOPOLYMERIZABLE HOE COMPOSITION | Xetos AG (DE) | 2023-12-20 | — | — | EP | disclosed |
| US-20230331604-A1 | METHOD FOR THE ELECTROCHEMICAL CONTROL OF THE PHOTOSYNTHETIC METABOLISM OF PURPLE NON-SULFUR BACTERIA AND REDOX MEDIATORS THEREOF | ZUCCATO HC S.R.L. (IT) | 2023-10-19 | — | — | US | disclosed |
| EP-4043961-B1 | 2K SYSTEM | XETOS AG (DE) | 2023-08-16 | — | — | EP | disclosed |
| EP-4043963-B1 | IMPROVED BLEACHING | XETOS AG (DE) | 2023-07-05 | — | — | EP | disclosed |
| US-20230149399-A1 | TREATMENT OF CANCER, INFLAMMATORY DISEASES AND AUTOIMMUNE DISEASES | USHER III INITIATIVE, INC. | 2023-05-18 | — | — | US | disclosed |
| EP-3307742-B1 | METHODS OF TREATING OR PREVENTING A PROTEOPATHY | USHER III INITIATIVE INC (US) | 2022-05-18 | — | — | EP | disclosed |
| WO-2021237084-A1 | METHYLENE BLUE STABILIZED MRNA COMPOSITIONS | MODERNATX, INC. (US) | 2021-11-25 | — | — | WO | disclosed |
| US-10982343-B2 | Plating compositions for electrolytic copper deposition, its use and a method for electrolytically depositing a copper or copper alloy layer onto at least one surface of a substrate | ATOTECH DEUTSCHLAND GMBH (DE) | 2021-04-20 | — | — | US | disclosed |
| US-20210063411-A1 | DETECTING TARGETS USING MASS TAGS AND MASS SPECTROMETRY | VENTANA MED SYST INC (US) | 2021-03-04 | — | — | US | disclosed |
| US-7169535-B2 | Photosensitive composition and photosensitive lithographic printing plate | KONICA MINOLTA HOLDINGS, INC. (JP) | 2007-01-30 | — | — | US | disclosed |
| EP-1727513-A1 | HAIR COLORING AGENT CONTAINING INDIGOID VAT DYES | Wella Aktiengesellschaft (DE) | 2006-12-06 | — | — | EP | disclosed |
| WO-2005124456-A2 | PHOTOPOLYMERISABLE COMPOSITION | XETOS AG (DE) | 2005-12-29 | — | — | WO | disclosed |
| WO-2005094763-A1 | HAIR COLORING AGENT CONTAINING INDIGOID VAT DYES | WELLA AKTIENGESELLSCHAFT (DE) | 2005-10-13 | — | — | WO | disclosed |
| EP-1492494-A1 | METHOD FOR TREATING HAIR WITH FORM MEMORY POLYMERS | Mnemoscience GmbH (DE) | 2005-01-05 | — | — | EP | disclosed |
| WO-2003084491-A1 | METHOD FOR TREATING HAIR WITH FORM MEMORY POLYMERS | MNEMOSCIENCE GMBH (DE) | 2003-10-16 | — | — | WO | disclosed |
| EP-1185531-A1 | CATIONIC PYRROLO-PYRROL-DERIVATIVES, METHOD FOR PRODUCING THEM AND COLORANTS FOR KERATIN FIBRES, CONTAINING THESE COMPOUNDS | Wella Aktiengesellschaft (DE) | 2002-03-13 | — | — | EP | disclosed |
| WO-2001062759-A1 | CATIONIC PYRROLO-PYRROL-DERIVATIVES, METHOD FOR PRODUCING THEM AND COLORANTS FOR KERATIN FIBRES, CONTAINING THESE COMPOUNDS | WELLA AKTIENGESELLSCHAFT (DE) | 2001-08-30 | — | — | WO | disclosed |
| EP-0705597-A1 | Process of direct hair dyeing using cationic direct dyes and steam | L'OREAL (FR) | 1996-04-10 | — | — | EP | disclosed |
| US-4137402-A | Quaternary ammonium salts of dantrolene and clodanolene | MORTON-NORWICH PRODUCTS, INC. (US) | 1979-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230149399-A1 | TREATMENT OF CANCER, INFLAMMATORY DISEASES AND AUTOIMMUNE DISEASES | TNF, HLA-DRB1, GSTK1 | NPC1 1858/4885RAB9A 2304/4885L3MBTL1 3209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.